England’s drug approval body resists pharma pressure to loosen processes
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. England’s drug approval body
No, not beds. NHS needs better business processes
[ad_1] Given the descriptions of how certain European countries have had better experience with managing A&E waiting times than the UK, it is odd that
